FY27 Revenue Growth Significantly Higher Than 30%
Management indicated that FY27 revenue growth will be 'much much higher' than 30%, driven by new centers and the government contract.
CHANDANHEALTHCARE / guidance tracker
Keep management guidance in view.
Chandan Healthcare · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
EBITDA Margin Improvement to 30-35%
Management expects consolidated EBITDA margins to improve to 30-35% as new centers mature and the one-time gratuity impact fades.
1000 Franchisee Locations in 3 Years
Target to enroll 1,000 franchisee collection centers over the next three years, with 100 already enrolled.
Capex of ₹100 Cr Over 3 Years for Labs
Planned investment of approximately ₹100 Cr over three years for setting up new laboratories, funded via preferential shares.